Lumos Diagnostics Holdings Ltd (LDX) - Net Assets

Latest as of December 2025: AU$5.24 Million AUD ≈ $3.70 Million USD

Based on the latest financial reports, Lumos Diagnostics Holdings Ltd (LDX) has net assets worth AU$5.24 Million AUD (≈ $3.70 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$21.12 Million ≈ $14.94 Million USD) and total liabilities (AU$15.88 Million ≈ $11.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LDX tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$5.24 Million
% of Total Assets	24.79%
Annual Growth Rate	10.92%
5-Year Change	-89.44%
10-Year Change	N/A
Growth Volatility	122.84

Lumos Diagnostics Holdings Ltd - Net Assets Trend (2017–2024)

This chart illustrates how Lumos Diagnostics Holdings Ltd's net assets have evolved over time, based on quarterly financial data. See Lumos Diagnostics Holdings Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Lumos Diagnostics Holdings Ltd (2017–2024)

The table below shows the annual net assets of Lumos Diagnostics Holdings Ltd from 2017 to 2024. For live valuation and market cap data, see how much is Lumos Diagnostics Holdings Ltd worth.

Year	Net Assets	Change
2024-12-31	AU$6.16 Million ≈ $4.36 Million	-13.39%
2023-12-31	AU$7.11 Million ≈ $5.03 Million	-25.15%
2022-12-31	AU$9.50 Million ≈ $6.72 Million	-46.89%
2021-12-31	AU$17.89 Million ≈ $12.65 Million	-69.31%
2020-12-31	AU$58.28 Million ≈ $41.24 Million	+163.05%
2019-12-31	AU$22.16 Million ≈ $15.68 Million	+90.02%
2018-12-31	AU$11.66 Million ≈ $8.25 Million	+291.20%
2017-12-31	AU$2.98 Million ≈ $2.11 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Lumos Diagnostics Holdings Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 9780846429.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	AU$103.96 Million	1688.53%
Other Comprehensive Income	AU$35.00K	0.57%
Total Equity	AU$6.16 Million	100.00%

Lumos Diagnostics Holdings Ltd Competitors by Market Cap

The table below lists competitors of Lumos Diagnostics Holdings Ltd ranked by their market capitalization.

Company	Market Cap
Innovate Corp NYSE:VATE	$68.68 Million
Plastron Precision Co Ltd TWO:6185	$68.70 Million
TSA KLSE:0297	$68.72 Million
Groupe LDLC SA PA:ALLDL	$68.73 Million
Ace Technologies Corp KQ:088800	$68.63 Million
Superior Plating Technology Co Ltd TWO:8431	$68.61 Million
Cheviot Company Limited NSE:CHEVIOT	$68.59 Million
Samart Telcoms Public Company Limited BK:SAMTEL	$68.57 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Lumos Diagnostics Holdings Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 7,109,000 to 6,157,000, a change of -952,000 (-13.4%).
Net loss of 7,183,000 reduced equity.
Share repurchases of 6,222,000 reduced equity.
New share issuances of 6,222,000 increased equity.
Other comprehensive income increased equity by 294,000.
Other factors increased equity by 5,937,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	AU$-7.18 Million	-116.66%
Share Repurchases	AU$6.22 Million	-101.06%
Share Issuances	AU$6.22 Million	+101.06%
Other Comprehensive Income	AU$294.00K	+4.78%
Other Changes	AU$5.94 Million	+96.43%
Total Change	AU$-	-13.39%

Book Value vs Market Value Analysis

This analysis compares Lumos Diagnostics Holdings Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 11.60x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 0.59x to 11.60x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	AU$0.18	AU$0.11	x
2018-12-31	AU$0.69	AU$0.11	x
2019-12-31	AU$1.00	AU$0.11	x
2020-12-31	AU$0.39	AU$0.11	x
2021-12-31	AU$0.12	AU$0.11	x
2022-12-31	AU$0.04	AU$0.11	x
2023-12-31	AU$0.01	AU$0.11	x
2024-12-31	AU$0.01	AU$0.11	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Lumos Diagnostics Holdings Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -116.66%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -57.46%
• Asset Turnover: 0.60x
• Equity Multiplier: 3.38x
Recent ROE (-116.66%) is below the historical average (-92.15%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2017	-42.49%	-65.98%	0.22x	2.98x	AU$-1.56 Million
2018	-39.41%	-102.57%	0.18x	2.18x	AU$-5.76 Million
2019	-41.89%	-160.16%	0.19x	1.37x	AU$-11.50 Million
2020	-25.79%	-79.72%	0.19x	1.68x	AU$-20.86 Million
2021	-255.66%	-393.16%	0.31x	2.07x	AU$-47.51 Million
2022	-94.45%	-85.15%	0.41x	2.68x	AU$-9.92 Million
2023	-120.86%	-77.19%	0.41x	3.78x	AU$-9.30 Million
2024	-116.66%	-57.46%	0.60x	3.38x	AU$-7.80 Million

Industry Comparison

This section compares Lumos Diagnostics Holdings Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $188,148,395
Average return on equity (ROE) among peers: -40.74%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Lumos Diagnostics Holdings Ltd (LDX)	AU$5.24 Million	-42.49%	3.03x	$68.64 Million
4DMEDICAL Ltd (4DX)	$83.36 Million	-25.70%	0.11x	$1.63 Billion
Adherium Ltd (ADR)	$14.04 Million	-107.13%	0.21x	$7.60 Million
Aroa Biosurgery Ltd (ARX)	$4.76 Million	0.00%	0.70x	$157.02 Million
Atomo Diagnostics Ltd (AT1)	$30.09 Million	-20.01%	0.07x	$11.48 Million
Avita Medical Inc (AVH)	$20.86 Million	-118.03%	0.23x	$124.67 Million
Anteris Technologies Global Corp (AVR)	$13.64 Million	-10.42%	0.08x	$848.00 Million
Control Bionics Ltd (CBL)	$5.05 Million	-38.22%	0.07x	$21.86 Million
Cardiex Ltd (CDX)	$1.88 Million	-105.36%	1.22x	$13.23 Million
Compumedics Ltd (CMP)	$18.21 Million	-1.86%	1.22x	$35.34 Million
Cochlear Ltd (COH)	$1.69 Billion	19.32%	0.44x	$4.75 Billion

About Lumos Diagnostics Holdings Ltd

AU:LDX Australia Medical Devices

Market Cap

$68.64 Million

AU$97.01 Million AUD

Market Cap Rank

#20623 Global

#699 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.32

All Time High

AU$1.22